Prodia Diagnostic Line Tbk vs Charlie Hospital Semarang Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp310 (market cap 816.2B, 25.44M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is the larger of the two by market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 25.44M). Which is the better fit depends on your goals.
| PRDL | RSCH | |
|---|---|---|
Market Cap | 470.58B | 816.2B |
Volume | 28.43M | 25.44M |
Lot | 284.34K | 254.36K |
Turnover | 7.8B | 7.84B |
Average Price | 274.19 | 308.07 |
Value | 7.8B | 7.84B |
Indicative Equilibrium Price | 270 | 310 |
Indicative Equilibrium Volume | 2.1K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →